Press Releases
Wake Forest Baptist Medical Center Joins the TriNetX Global Health Research Network
Cambridge, MA, August 7, 2017—TriNetX is pleased to announce the addition of Wake Forest Baptist Medical Center to the TriNetX health research network. Wake Forest Baptist, a nationally recognized academic medical center and health system based in Winston-Salem, NC,...
Premier Research Joins TriNetX Global Health Research Network to Access Real-Time Site & Patient Metrics
DURHAM, N.C., JULY 24, 2017 — Premier Research, seeking to accelerate clinical trial design and patient recruitment to better serve its highly innovative customers, has signed an agreement with TriNetX to allow direct query access to its global health research...
Universitätsklinikum Erlangen, Germany Signs on to the TriNetX Health Research Network
Cambridge, MA, July 13, 2017 —The Universitätsklinikum Erlangen (UK Erlangen) has joined the TriNetX health research network, becoming the first healthcare organization in Germany to join TriNetX. The UK Erlangen dataset covers more than one million patient lives and...
TriNetX Announces Availability of OMOP Common Data Model Toolkit for Data Acquisition
Cambridge, MA, June 28, 2017 — TriNetX, the global health research network for healthcare organizations, biopharma, and contract research organizations (CROs), announced support for the Observational Medical Outcomes Partnership (OMOP) common data model. Combined with...
InformedDNA Joins the TriNetX Health Research Network
Cambridge, MA, June 14, 2017 — InformedDNA, the nation’s largest independent provider of genetic counseling, announced it has joined the TriNetX health research network comprised of healthcare organizations representing over 84 million patients globally,...
Virginia Commonwealth University Joins the TriNetX Health Research Network
CAMBRIDGE, Mass., May 24, 2017 – Virginia Commonwealth University (VCU) has joined the TriNetX health research network, which is comprised of healthcare organizations representing over 84 million patients globally, biopharmaceutical companies and contract research...
